Intestinal microflora and metabolic diseases

Sears, 2005, A dynamic partnership: celebrating our gut flora, Anaerobe, 11, 247, 10.1016/j.anaerobe.2005.05.001 Berg, 1996, The indigenous gastrointestinal microflora, Trends Microbiol, 4, 430, 10.1016/0966-842X(96)10057-3 Mackie, 1999, Developmental microbial ecology of the neonatal gastrointestinal tract, Am J Clin Nutr, 69, 1035S, 10.1093/ajcn/69.5.1035s Gorbach, 1971, Intestinal microflora, Gastroenterology, 60, 1110, 10.1016/S0016-5085(71)80039-2 Wolowczuk, 2008, Feeding our immune system: impact on metabolism, Clin Dev Immunol, 2008, 639803, 10.1155/2008/639803 Schenk, 2008, The mucosal immune system at the gastrointestinal barrier, Best Pract Res Clin Gastroenterol, 22, 391, 10.1016/j.bpg.2007.11.002 Sudo, 1997, The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction, J Immunol, 159, 1739, 10.4049/jimmunol.159.4.1739 Niess, 2008, Role of mucosal dendritic cells in inflammatory bowel disease, World J Gastroenterol, 14, 5138, 10.3748/wjg.14.5138 Strober, 2006, Unraveling gut inflammation, Science, 313, 1052, 10.1126/science.1131997 Xavier, 2007, Unravelling the pathogenesis of inflammatory bowel disease, Nature, 448, 427, 10.1038/nature06005 Rouzaud, 2003, Influence of plant and bacterial myrosinase activity on the metabolic fate of glucosinolates in gnotobiotic rats, Br J Nutr, 90, 395, 10.1079/BJN2003900 Possemiers, 2008, Eubacterium limosum activates isoxanthohumol from hops (Humulus lupulus L) into the potent phytoestrogen 8-prenylnaringenin in vitro and in rat intestine, J Nutr, 138, 1310, 10.1093/jn/138.7.1310 Yuan, 2007, Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health, Mol Nutr Food Res, 51, 765, 10.1002/mnfr.200600262 Wong, 2007, Carbohydrate digestibility and metabolic effects, J Nutr, 137, 2539S, 10.1093/jn/137.11.2539S O’Hara, 2006, The gut flora as a forgotten organ, EMBO Rep, 7, 688, 10.1038/sj.embor.7400731 Zoetendal, 2006, A microbial world within us, Mol Microbiol, 59, 1639, 10.1111/j.1365-2958.2006.05056.x Gorbach, 1990, Lactic acid bacteria and human health, Ann Med, 22, 37, 10.3109/07853899009147239 Salminen, 2005, Probiotics that modify disease risk, J Nutr, 135, 1294, 10.1093/jn/135.5.1294 Ouwehand, 2002, The role of the intestinal microflora for the development of the immune system in early childhood, Eur J Nutr, 41, I32 Rolfe, 1984, Interactions among microorganisms of the indigenous intestinal flora and their influence on the host, Rev Infect Dis, 6, S73, 10.1093/clinids/6.Supplement_1.S73 Abrams, 1967, Effect of the normal microbial flora on gastrointestinal motility, Proc Soc Exp Biol Med, 126, 301, 10.3181/00379727-126-32430 Stappenbeck, 2002, Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells, Proc Natl Acad Sci U S A, 99, 15451, 10.1073/pnas.202604299 Mathan, 1989, Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora, Gut, 30, 971, 10.1136/gut.30.7.971 Hooper, 2001, Molecular analysis of commensal host-microbial relationships in the intestine, Science, 291, 881, 10.1126/science.291.5505.881 Bouskra, 2008, Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis, Nature, 456, 507, 10.1038/nature07450 Lee, 2003, Escherichia coli--a model system that benefits from and contributes to the evolution of proteomics, Biotechnol Bioeng, 84, 801, 10.1002/bit.10848 Gill, 2006, Metagenomic analysis of the human distal gut microbiome, Science, 312, 1355, 10.1126/science.1124234 Palmer, 2007, Development of the Human Infant Intestinal Microbiota, PLoS Biol, 5, e177, 10.1371/journal.pbio.0050177 Eckburg, 2005, Diversity of the human intestinal microbial flora, Science, 308, 1635, 10.1126/science.1110591 Macfarlane, 2004, Bacterial diversity in the human gut, Adv Appl Microbiol, 54, 261, 10.1016/S0065-2164(04)54010-8 Ginzinger, 2002, Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream, Exp Hematol, 30, 503, 10.1016/S0301-472X(02)00806-8 Zaneveld, 2008, Host-bacterial coevolution and the search for new drug targets, Curr Opin Chem Biol, 12, 109, 10.1016/j.cbpa.2008.01.015 Shoelson, 2006, Inflammation and insulin resistance, J Clin Invest, 116, 1793, 10.1172/JCI29069 Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 Podolsky, 2002, Inflammatory bowel disease, N Engl J Med, 347, 417, 10.1056/NEJMra020831 Fuss, 2004, Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis, J Clin Invest, 113, 1490, 10.1172/JCI19836 de Wit, 2008, The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice, BMC Med Genomics, 1, 14, 10.1186/1755-8794-1-14 Swidsinski, 2002, Mucosal flora in inflammatory bowel disease, Gastroenterology, 122, 44, 10.1053/gast.2002.30294 Rath, 1996, Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats, J Clin Invest, 98, 945, 10.1172/JCI118878 Sellon, 1998, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice, Infect Immun, 66, 5224, 10.1128/IAI.66.11.5224-5231.1998 Pozzilli, 1993, NOD mouse colonies around the world--recent facts and figures, Immunol Today, 14, 193, 10.1016/0167-5699(93)90160-M McInerney, 1991, Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice, Diabetes, 40, 715, 10.2337/diabetes.40.6.715 Sadelain, 1990, Prevention of type I diabetes in NOD mice by adjuvant immunotherapy, Diabetes, 39, 583, 10.2337/diabetes.39.5.583 Wen, 2008, Innate immunity and intestinal microbiota in the development of type 1 diabetes, Nature, 455, 1109, 10.1038/nature07336 Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Meddings, 1999, Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat, Am J Physiol, 276, G951 Graham, 2004, Enteropathy precedes type 1 diabetes in the BB rat, Gut, 53, 1437, 10.1136/gut.2004.042481 Neu, 2005, Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes, J Pediatr Gastroenterol Nutr, 40, 589, 10.1097/01.MPG.0000159636.19346.C1 Bosi, 2006, Increased intestinal permeability precedes clinical onset of type 1 diabetes, Diabetologia, 49, 2824, 10.1007/s00125-006-0465-3 Formiguera, 2004, Obesity: epidemiology and clinical aspects, Best Pract Res Clin Gastroenterol, 18, 1125, 10.1016/S1521-6918(04)00091-5 Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature, 444, 1022, 10.1038/4441022a Backhed, 2004, The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci U S A, 101, 15718, 10.1073/pnas.0407076101 Backhed, 2005, Host-bacterial mutualism in the human intestine, Science, 307, 1915, 10.1126/science.1104816 Backhed, 2007, Mechanisms underlying the resistance to diet-induced obesity in germ-free mice, Proc Natl Acad Sci U S A, 104, 979, 10.1073/pnas.0605374104 Kersten, 2000, Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene, J Biol Chem, 275, 28488, 10.1074/jbc.M004029200 Turnbaugh, 2007, The human microbiome project, Nature, 449, 804, 10.1038/nature06244 Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491 Cani, 2008, Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, Diabetes, 57, 1470, 10.2337/db07-1403 Cani, 2008, Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding, Pathol Biol (Paris), 56, 305, 10.1016/j.patbio.2007.09.008 Cani, 2007, Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia, Diabetologia, 50, 2374, 10.1007/s00125-007-0791-0 Ley, 2005, Obesity alters gut microbial ecology, Proc Natl Acad Sci U S A, 102, 11070, 10.1073/pnas.0504978102 Ghoshal, 2009, Chylomicrons promote intestinal absorption of lipopolysaccharides, J Lipid Res, 50, 90, 10.1194/jlr.M800156-JLR200 Vreugdenhil, 2003, Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons, J Immunol, 170, 1399, 10.4049/jimmunol.170.3.1399 Amar, 2008, Energy intake is associated with endotoxemia in apparently healthy men, Am J Clin Nutr, 87, 1219, 10.1093/ajcn/87.5.1219 Ferrier, 2006, Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents, Am J Pathol, 168, 1148, 10.2353/ajpath.2006.050617 Membrez, 2008, Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice, Faseb J, 22, 2416, 10.1096/fj.07-102723 Chou, 2008, Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice, Nestle Nutr Workshop Ser Pediatr Program, 62, 127, 10.1159/000146256 Langlands, 2004, Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel, Gut, 53, 1610, 10.1136/gut.2003.037580 Lesniewska, 2006, Effect on components of the intestinal microflora and plasma neuropeptide levels of feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and inulin to adult and elderly rats, Appl Environ Microbiol, 72, 6533, 10.1128/AEM.00915-06 Kleessen, 2001, Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora, Br J Nutr, 86, 291, 10.1079/BJN2001403 Cani, 2005, Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats, J Endocrinol, 185, 457, 10.1677/joe.1.06100 Pickup, 1998, Is type II diabetes mellitus a disease of the innate immune system?, Diabetologia, 41, 1241, 10.1007/s001250051058 Shi, 2006, TLR4 links innate immunity and fatty acid-induced insulin resistance, J Clin Invest, 116, 3015, 10.1172/JCI28898 Holst, 2007, The physiology of glucagon-like peptide 1, Physiol Rev, 87, 1409, 10.1152/physrev.00034.2006 Burcelin, 2005, The incretins: a link between nutrients and well-being, Br J Nutr, 93, S147, 10.1079/BJN20041340 Knauf, 2005, Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage, J Clin Invest, 115, 3554, 10.1172/JCI25764 Burcelin, 2007, Glucagon-like peptide-1 and energy homeostasis, J Nutr, 137, 2534S, 10.1093/jn/137.11.2534S Burcelin, 2001, Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor, Diabetes, 50, 1720, 10.2337/diabetes.50.8.1720 Knauf, 2008, Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure, Endocrinology, 149, 4768, 10.1210/en.2008-0180 Knauf, 2008, Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing, Diabetes, 57, 2603, 10.2337/db07-1788 Cabou, 2008, Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity, Diabetes, 57, 2577, 10.2337/db08-0121 Ahren, 2008, Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes, Expert Opin Emerg Drugs, 13, 593, 10.1517/14728210802584126 Drucker, 2006, The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes, Lancet, 368, 1696, 10.1016/S0140-6736(06)69705-5 Gibson, 1995, Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J Nutr, 125, 1401, 10.1093/jn/125.6.1401 Gibson, 1999, Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin, J Nutr, 129, 1438S, 10.1093/jn/129.7.1438S Watanabe, 2008, Consumption of fructo-oligosaccharide reduces 2, 4-dinitrofluorobenzene-induced contact hypersensitivity in mice, Br J Nutr, 100, 339, 10.1017/S0007114507901221 Rautava, 2008, Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study, Br J Nutr, 1 Al-Salami, 2008, Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats, Eur J Drug Metab Pharmacokinet, 33, 101, 10.1007/BF03191026 Bajaj, 2008, Probiotic yogurt for the treatment of minimal hepatic encephalopathy, Am J Gastroenterol, 103, 1707, 10.1111/j.1572-0241.2008.01861.x Yadav, 2008, Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats, J Dairy Res, 75, 189, 10.1017/S0022029908003129 Li, 2003, Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease, Hepatology, 37, 343, 10.1053/jhep.2003.50048 Ma, 2008, Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells, J Hepatol, 49, 821, 10.1016/j.jhep.2008.05.025 Mazmanian, 2008, A microbial symbiosis factor prevents intestinal inflammatory disease, Nature, 453, 620, 10.1038/nature07008